These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 24244383)
1. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells. Schuurhuis GJ; Meel MH; Wouters F; Min LA; Terwijn M; de Jonge NA; Kelder A; Snel AN; Zweegman S; Ossenkoppele GJ; Smit L PLoS One; 2013; 8(11):e78897. PubMed ID: 24244383 [TBL] [Abstract][Full Text] [Related]
2. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients. Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165 [TBL] [Abstract][Full Text] [Related]
3. Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia. Moshaver B; Wouters RF; Kelder A; Ossenkoppele GJ; Westra GAH; Kwidama Z; Rutten AR; Kaspers GJL; Zweegman S; Cloos J; Schuurhuis GJ Leuk Res; 2019 Jun; 81():27-34. PubMed ID: 31002948 [TBL] [Abstract][Full Text] [Related]
4. The molecular signature of AML with increased ALDH activity suggests a stem cell origin. Blume R; Rempel E; Manta L; Saeed BR; Wang W; Raffel S; Ermakova O; Eckstein V; Benes V; Trumpp A; Ho AD; Lutz C Leuk Lymphoma; 2018 Sep; 59(9):2201-2210. PubMed ID: 29334844 [TBL] [Abstract][Full Text] [Related]
5. Identification and separation of normal hematopoietic stem cells and leukemia stem cells from patients with acute myeloid leukemia. Hoang VT; Hoffmann I; Borowski K; Zepeda-Moreno A; Ran D; Buss EC; Wuchter P; Eckstein V; Ho AD Methods Mol Biol; 2013; 1035():217-30. PubMed ID: 23959995 [TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Cheung AM; Wan TS; Leung JC; Chan LY; Huang H; Kwong YL; Liang R; Leung AY Leukemia; 2007 Jul; 21(7):1423-30. PubMed ID: 17476279 [TBL] [Abstract][Full Text] [Related]
7. Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells. Kornblau SM; Qutub A; Yao H; York H; Qiu YH; Graber D; Ravandi F; Cortes J; Andreeff M; Zhang N; Coombes KR PLoS One; 2013; 8(10):e78453. PubMed ID: 24223100 [TBL] [Abstract][Full Text] [Related]
8. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones. Al-Mawali A; Gillis D; Lewis I J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508 [TBL] [Abstract][Full Text] [Related]
9. [In Vitro Identification and Characteristics of CD34 Zhang YH; Yang L; Wang YZ; Kong Y; Zhu HH; Qin YZ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1289-1294. PubMed ID: 29070097 [TBL] [Abstract][Full Text] [Related]
10. Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia. Terwijn M; Zeijlemaker W; Kelder A; Rutten AP; Snel AN; Scholten WJ; Pabst T; Verhoef G; Löwenberg B; Zweegman S; Ossenkoppele GJ; Schuurhuis GJ PLoS One; 2014; 9(9):e107587. PubMed ID: 25244440 [TBL] [Abstract][Full Text] [Related]
11. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia. de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595 [TBL] [Abstract][Full Text] [Related]
12. A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia. Gerber JM; Smith BD; Ngwang B; Zhang H; Vala MS; Morsberger L; Galkin S; Collector MI; Perkins B; Levis MJ; Griffin CA; Sharkis SJ; Borowitz MJ; Karp JE; Jones RJ Blood; 2012 Apr; 119(15):3571-7. PubMed ID: 22262762 [TBL] [Abstract][Full Text] [Related]
13. The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. van Rhenen A; van Dongen GA; Kelder A; Rombouts EJ; Feller N; Moshaver B; Stigter-van Walsum M; Zweegman S; Ossenkoppele GJ; Jan Schuurhuis G Blood; 2007 Oct; 110(7):2659-66. PubMed ID: 17609428 [TBL] [Abstract][Full Text] [Related]